OKYO Pharma Limited
OKYO
$1.61
$0.042.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.22M | 4.22M | 1.56M | 1.56M | 987.20K |
| Total Receivables | 23.40K | 23.40K | 1.89M | 1.89M | 1.52M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 394.40K | 394.40K | 225.40K | 225.40K | 319.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.50K | 4.50K | -- | -- | 4.50K |
| Total Current Assets | 4.64M | 4.64M | 3.68M | 3.68M | 2.83M |
|
|
|||||
| Total Current Assets | 4.64M | 4.64M | 3.68M | 3.68M | 2.83M |
| Net Property, Plant & Equipment | 1.20K | 1.20K | 2.00K | 2.00K | 2.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.64M | 4.64M | 3.68M | 3.68M | 2.83M |
|
|
|||||
| Total Accounts Payable | 7.64M | 7.64M | 7.90M | 7.90M | 9.61M |
| Total Accrued Expenses | -- | -- | 1.24M | 1.24M | -- |
| Short-term Debt | 185.80K | 185.80K | -- | -- | 1.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 233.50K | 233.50K | 89.00K | 89.00K | 445.60K |
| Total Other Current Liabilities | 233.50K | 233.50K | 89.00K | 89.00K | 445.60K |
| Total Current Liabilities | 8.06M | 8.06M | 9.23M | 9.23M | 10.05M |
|
|
|||||
| Total Current Liabilities | 8.06M | 8.06M | 9.23M | 9.23M | 10.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 185.80K | 185.80K | -- | -- | 1.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.06M | 8.06M | 9.23M | 9.23M | 10.05M |
|
|
|||||
| Common Stock & APIC | 151.23M | 151.23M | 146.72M | 146.72M | 144.05M |
| Retained Earnings | -145.61M | -145.61M | -143.03M | -143.03M | -145.20M |
| Treasury Stock & Other | -9.03M | -9.03M | -9.24M | -9.24M | -6.07M |
| Total Common Equity | -3.42M | -3.42M | -5.55M | -5.55M | -7.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.42M | -3.42M | -5.55M | -5.55M | -7.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.42M | -3.42M | -5.55M | -5.55M | -7.23M |
|
|
|||||